NL192720B - Osmotische inrichting voor de afgifte van een voor een gebruiksomgeving voordelig middel. - Google Patents

Osmotische inrichting voor de afgifte van een voor een gebruiksomgeving voordelig middel.

Info

Publication number
NL192720B
NL192720B NL8400670A NL8400670A NL192720B NL 192720 B NL192720 B NL 192720B NL 8400670 A NL8400670 A NL 8400670A NL 8400670 A NL8400670 A NL 8400670A NL 192720 B NL192720 B NL 192720B
Authority
NL
Netherlands
Prior art keywords
delivering
environment
osmotic device
agent advantageous
advantageous
Prior art date
Application number
NL8400670A
Other languages
English (en)
Other versions
NL8400670A (nl
NL192720C (nl
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NL8400670A publication Critical patent/NL8400670A/nl
Publication of NL192720B publication Critical patent/NL192720B/nl
Application granted granted Critical
Publication of NL192720C publication Critical patent/NL192720C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
NL8400670A 1983-03-04 1984-03-01 Osmotische inrichting voor de afgifte van een voor een gebruiksomgeving voordelig middel. NL192720C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47233383 1983-03-04
US06/472,333 US4576604A (en) 1983-03-04 1983-03-04 Osmotic system with instant drug availability

Publications (3)

Publication Number Publication Date
NL8400670A NL8400670A (nl) 1984-10-01
NL192720B true NL192720B (nl) 1997-09-01
NL192720C NL192720C (nl) 1998-01-06

Family

ID=23875096

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8400670A NL192720C (nl) 1983-03-04 1984-03-01 Osmotische inrichting voor de afgifte van een voor een gebruiksomgeving voordelig middel.

Country Status (22)

Country Link
US (1) US4576604A (nl)
JP (1) JPS59167513A (nl)
AT (1) AT397179B (nl)
AU (1) AU568621B2 (nl)
BE (1) BE898820A (nl)
BR (1) BR8400997A (nl)
CA (1) CA1242122A (nl)
CH (1) CH660124A5 (nl)
DE (1) DE3407873A1 (nl)
DK (1) DK162470C (nl)
ES (1) ES530268A0 (nl)
FR (1) FR2541896B1 (nl)
GB (1) GB2135880B (nl)
IE (1) IE56606B1 (nl)
IL (1) IL71112A (nl)
IT (1) IT1182253B (nl)
MX (1) MX165227B (nl)
NL (1) NL192720C (nl)
NO (1) NO170667C (nl)
NZ (1) NZ206988A (nl)
SE (1) SE459847B (nl)
ZA (1) ZA84259B (nl)

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU571922B2 (en) * 1984-01-26 1988-04-28 Schering Agrochemicals Limited Veterinary implants comprising melatonin and derivatives thereof
US4618487A (en) * 1984-07-06 1986-10-21 Alza Corporation Device for administering calcium ascorbate
US4769027A (en) * 1984-08-15 1988-09-06 Burroughs Wellcome Co. Delivery system
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4786501A (en) * 1985-07-15 1988-11-22 International Minerals & Chemical Corp. Cylindrical implants for the controlled release of growth hormones
US4643731A (en) * 1985-08-16 1987-02-17 Alza Corporation Means for providing instant agent from agent dispensing system
US4698062A (en) * 1985-10-30 1987-10-06 Alza Corporation Medical device for pulsatile transdermal delivery of biologically active agents
US4898733A (en) * 1985-11-04 1990-02-06 International Minerals & Chemical Corp. Layered, compression molded device for the sustained release of a beneficial agent
US4662880A (en) * 1986-03-14 1987-05-05 Alza Corporation Pseudoephedrine, brompheniramine therapy
US4857330A (en) * 1986-04-17 1989-08-15 Alza Corporation Chlorpheniramine therapy
DE3766885D1 (en) * 1986-04-17 1991-02-07 Alza Corp Chlorpheniramine therapie.
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
AU601736B2 (en) * 1986-05-23 1990-09-20 Sanofi Sante Nutrition Animale Sa Coated veterinary implants
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
ATE75394T1 (de) * 1986-11-14 1992-05-15 Ciba Geigy Ag Orales osmotisches system fuer metoprolol mit verbesserten formulierungseigenschaften.
JPS63135179A (ja) * 1986-11-26 1988-06-07 立花　俊郎 薬物の経皮投与具
US4801461A (en) 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy
US5023076A (en) * 1987-02-27 1991-06-11 Alza Corporation Lamina comprising carboxyvinyl polymer
US4915952A (en) * 1987-02-27 1990-04-10 Alza Corporation Composition comprising drug, HPC, HPMC and PEO
GB2206046B (en) * 1987-06-25 1991-04-03 Alza Corp Multi-unit delivery system
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
GR1000252B (el) * 1988-09-02 1992-05-12 Alza Corp Μορφη δοσολογιας συνισταμενη απο ταχεια απελευθερωση δραστικου παραγοντα ακολουθουμενη απο βραδεια απελευθερωση δραστικου παραγοντα.
US5034229A (en) * 1988-12-13 1991-07-23 Alza Corporation Dispenser for increasing feed conversion of hog
US4969884A (en) * 1988-12-28 1990-11-13 Alza Corporation Osmotically driven syringe
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
US5200197A (en) * 1989-11-16 1993-04-06 Alza Corporation Contraceptive pill
US5045082A (en) * 1990-01-10 1991-09-03 Alza Corporation Long-term delivery device including loading dose
US5071607A (en) * 1990-01-31 1991-12-10 Alza Corporatino Method and apparatus for forming a hole in a drug dispensing device
US5192550A (en) * 1990-05-07 1993-03-09 Alza Corporation Dosage form for treating central nervous system disorders
US5221536A (en) 1990-05-07 1993-06-22 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5187100A (en) * 1990-05-29 1993-02-16 Lifescan, Inc. Dispersion to limit penetration of aqueous solutions into a membrane
US5128145A (en) * 1990-06-13 1992-07-07 Alza Corporation Dosage form for Parkinson's disease, spasticity and muscle spasms
EP0542926B1 (en) * 1990-08-07 1995-02-15 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
US5178867A (en) * 1991-08-19 1993-01-12 Alza Corporation Dosage form for delivering drug in short-time period
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5429822A (en) * 1992-03-13 1995-07-04 Cambridge Scientific, Inc. Biodegradable bursting release system
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US5540665A (en) * 1994-01-31 1996-07-30 Alza Corporation Gas driven dispensing device and gas generating engine therefor
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5595752A (en) * 1994-07-01 1997-01-21 Monsanto Company Increasing dressing percentage and carcass weight in finishing beef cattle
US5672357A (en) * 1994-07-01 1997-09-30 Monsanto Company Method and device for implantation of large diameter objects in bovines
US5914131A (en) * 1994-07-07 1999-06-22 Alza Corporation Hydromorphone therapy
US5529787A (en) * 1994-07-07 1996-06-25 Alza Corporation Hydromorphone therapy
US6491945B1 (en) * 1994-09-16 2002-12-10 Alza Corporation Hydrocodone therapy
US6283951B1 (en) * 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
DE69709646T2 (de) * 1996-03-12 2002-08-14 Alza Corp Zusammensetzung und dosisform mit einem opioid-antagonisten
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US5948787A (en) * 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
ATE250929T1 (de) * 1997-05-30 2003-10-15 Osmotica Corp Mehrlagige osmosevorrichtung
US8524277B2 (en) * 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
US20020127254A1 (en) * 1998-06-25 2002-09-12 Lavipharm Laboratories Inc. Devices for local and systemic delivery of active substance and methods of manufacturing thereof
US20090297602A1 (en) * 1998-11-02 2009-12-03 Devane John G Modified Release Loxoprofen Compositions
US6198966B1 (en) 1999-02-26 2001-03-06 Medtronic, Inc. Recirculating implantable drug delivery system
WO2000062759A1 (en) 1999-04-16 2000-10-26 Novo Nordisk A/S Dry, mouldable drug formulation
US6264973B1 (en) * 1999-08-26 2001-07-24 Fei Enterprises, Ltd. Apparatus and method for anesthetizing the cervical region of a female
ES2233611T3 (es) 2000-02-04 2005-06-16 Alza Corporation Dispensador de fluidos de accionamiento osmotico.
US6464688B1 (en) 2000-02-15 2002-10-15 Microsolutions, Inc. Osmotic pump delivery system with flexible drug compartment
ATE355813T1 (de) * 2000-07-14 2007-03-15 Novo Nordisk As Verfahren zum formen einer pharmazeutischen zusammensetzung in einem verpackungsmaterial
ATE330586T1 (de) * 2001-03-14 2006-07-15 Pfizer Prod Inc Pharmazeutische tablette und eine verfahren zu deren herstellung
US6632217B2 (en) 2001-04-19 2003-10-14 Microsolutions, Inc. Implantable osmotic pump
MXPA04002980A (es) * 2001-09-28 2005-06-20 Johnson & Johnson Formas de dosificacion que tienen un nucleo interior y coraza exterior con diferentes formas.
US20030228368A1 (en) * 2001-09-28 2003-12-11 David Wynn Edible solid composition and dosage form
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US20040253312A1 (en) 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
WO2003051328A1 (en) * 2001-12-18 2003-06-26 Novo Nordisk A/S Solid dose micro implant
US8454997B2 (en) * 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
DK1551372T3 (en) * 2002-09-20 2018-07-23 Alpharma Pharmaceuticals Llc SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES
EP2255795A1 (en) 2002-09-28 2010-12-01 McNeil-PPC, Inc. Immediate release dosage form comprising shell having openings therein
US20070077301A1 (en) * 2002-12-23 2007-04-05 Meyer Glenn A Venlafaxine osmotic device formulation
US8029822B2 (en) * 2003-05-22 2011-10-04 Osmotica Kereskedelmi és Seolgáltató KFT Rupturing controlled release device having a preformed passageway
AU2004283196B2 (en) * 2003-09-17 2011-08-25 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds
NZ546183A (en) * 2003-09-26 2011-04-29 Alza Corp Controlled release formulations exhibiting an ascending rate of release
JP5563731B2 (ja) * 2003-09-26 2014-07-30 アルザ・コーポレーシヨン オピオイドおよび非オピオイド鎮痛薬の制御放出製剤
MXPA06003453A (es) * 2003-09-26 2006-08-31 Johnson & Johnson Barra de empuje oros para el suministro controlado de agentes activos.
NZ546148A (en) 2003-09-26 2009-05-31 Alza Corp Drug coating providing high drug loading and methods for providing the same
US20050129764A1 (en) * 2003-12-11 2005-06-16 Vergez Juan A. Osmotic device containing licofelone
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US20050196447A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196448A1 (en) * 2004-03-05 2005-09-08 Hai Yong Huang Polymeric compositions and dosage forms comprising the same
US20050196442A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196446A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
WO2006052742A2 (en) * 2004-11-05 2006-05-18 Smithkline Beecham Corporation Pharmaceutical analysis apparatus and method
US20060104931A1 (en) * 2004-11-12 2006-05-18 Takeshi Fukutome Cosmetic treatment article comprising substrate and gel composition
AR053986A1 (es) 2004-12-03 2007-05-30 Osmotica Pharmaceutical Argent Dispositivo osmotico que contiene amantadina y una sal osmotica
US7530804B2 (en) * 2004-12-07 2009-05-12 Mcneil-Ppc, Inc. System and process for providing at least one opening in dosage forms
US20060233882A1 (en) * 2005-04-15 2006-10-19 Sowden Harry S Osmotic dosage form
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
JP5095615B2 (ja) 2005-06-27 2012-12-12 バリアント・インターナショナル・（バルバドス）・ソサイアティーズ・ウィズ・リストリクティッド・ライアビリティ ブプロピオン塩の放出調整製剤
US7598255B2 (en) 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
DE602006018529D1 (de) 2005-12-29 2011-01-05 Osmotica Kereskedelmi Es Szolgaltato Kft Mehrschichtige tablette mit dreifacher freisetzungskombination
US20090069343A1 (en) * 2006-04-10 2009-03-12 Dunford Paul J Combination Histamine H1R and H4R Antagonist Therapy for Treating Pruritus
US8137327B2 (en) * 2006-06-16 2012-03-20 Family Health International Vaginal drug delivery system and method
CN101677963B (zh) 2006-06-19 2012-05-30 奥尔制药公司 药物组合物
US20080075771A1 (en) * 2006-07-21 2008-03-27 Vaughn Jason M Hydrophilic opioid abuse deterrent delivery system using opioid antagonists
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
AU2008346870A1 (en) * 2007-12-17 2009-07-16 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US20090311335A1 (en) * 2008-06-12 2009-12-17 Scott Jenkins Combination of a triptan and an nsaid
DK2328539T3 (en) 2008-09-25 2018-06-18 Isp Investments Llc SOFT TABLET COATING COMPOSITION WITH HIGH DRY CONTENT
DE102008059206A1 (de) * 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
US20100260858A1 (en) * 2009-04-09 2010-10-14 Elan Pharma International Limited Drug delivery composition
SG11201406363VA (en) 2012-05-07 2014-11-27 Bayer Pharma AG Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil
CA2932290C (en) 2013-12-06 2023-06-13 Durect Corporation Compositions comprising antioxidant, fluid dispensers, and methods involving the same
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
WO2018115888A1 (en) 2016-12-21 2018-06-28 N4 Pharma Uk Limited Novel formulations of aprepitant
US9707217B1 (en) 2017-02-03 2017-07-18 Osmotica Kereskedelmi Es Szolgaltato Kft Dose-dumping resistant controlled release dosage form
CA3069158A1 (en) 2017-07-10 2019-01-17 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
US10744313B2 (en) * 2017-07-27 2020-08-18 University Of Utah Research Foundation Therapeutic delivery device

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2099402A (en) * 1934-01-17 1937-11-16 Pratt Food Company Pill or tablet
US2921001A (en) * 1957-04-16 1960-01-12 Sterling Drug Inc Multi-layered pill or tablet with indicating lamination
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
US3625214A (en) * 1970-05-18 1971-12-07 Alza Corp Drug-delivery device
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
AU466503B2 (en) * 1972-06-05 1975-10-30 Alza Corporation Osmotic dispenser
US4096238A (en) * 1974-12-23 1978-06-20 Alza Corporation Method for administering drug to the gastrointestinal tract
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4014334A (en) * 1976-02-02 1977-03-29 Alza Corporation Laminated osmotic system for dispensing beneficial agent
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
US4455143A (en) * 1982-03-22 1984-06-19 Alza Corporation Osmotic device for dispensing two different medications

Also Published As

Publication number Publication date
SE8401185D0 (sv) 1984-03-02
SE459847B (sv) 1989-08-14
FR2541896A1 (fr) 1984-09-07
IE56606B1 (en) 1991-10-09
GB8400563D0 (en) 1984-02-15
DK88884A (da) 1984-09-05
NL8400670A (nl) 1984-10-01
DE3407873C2 (nl) 1992-10-08
JPS59167513A (ja) 1984-09-21
CA1242122A (en) 1988-09-20
FR2541896B1 (fr) 1987-07-24
DK162470B (da) 1991-11-04
NO170667B (no) 1992-08-10
MX165227B (es) 1992-10-30
CH660124A5 (de) 1987-03-31
NL192720C (nl) 1998-01-06
US4576604A (en) 1986-03-18
NO170667C (no) 1992-11-18
ATA72784A (de) 1993-07-15
NZ206988A (en) 1986-04-11
NO840725L (no) 1984-09-05
DK162470C (da) 1992-04-06
IL71112A (en) 1986-09-30
IE840156L (en) 1984-09-04
DE3407873A1 (de) 1984-09-06
IL71112A0 (en) 1984-05-31
IT8467204A0 (it) 1984-03-02
GB2135880A (en) 1984-09-12
AU2306884A (en) 1984-09-06
SE8401185L (sv) 1984-09-05
GB2135880B (en) 1986-10-01
AT397179B (de) 1994-02-25
ZA84259B (en) 1985-02-27
IT1182253B (it) 1987-10-05
ES8503499A1 (es) 1985-03-01
BE898820A (fr) 1984-05-30
ES530268A0 (es) 1985-03-01
JPS644489B2 (nl) 1989-01-25
BR8400997A (pt) 1984-10-09
AU568621B2 (en) 1988-01-07
DK88884D0 (da) 1984-02-22

Similar Documents

Publication Publication Date Title
NL192720B (nl) Osmotische inrichting voor de afgifte van een voor een gebruiksomgeving voordelig middel.
NL192250B (nl) Osmotische inrichting voor de afgifte met een geregelde snelheid van een heilzaam middel.
NL172723B (nl) Inrichting voor het aanbrengen van een snede in de aarsstreek van een vogel.
NL193164B (nl) Farmaceutisch tablet voor gecontroleerde, langdurige afgifte van een actieve verbinding.
NL7710159A (nl) Afgedichte houder en werkwijze voor de vorming van een dergelijke houder.
NL188834C (nl) Inrichting voor het corrigeren van een abnormale hartactiviteit.
NL7608736A (nl) Werkwijze en inrichting voor het maken van een tomogram.
NL187504C (nl) Inrichting voor het weergeven van golfvormen.
NL190486C (nl) Guanidinederivaten en werkwijze voor de bereiding van een deel van deze guanidinederivaten.
NL7802043A (nl) Instrument voor het inbrengen van een intra-ute- rine anticonceptiemiddel, alsmede een werkwijze voor het inbrengen van een intra-uterine anti- conceptiemiddel.
NL191793C (nl) Werkwijze voor de bereiding van een polypeptide, en van een farmaceutisch of veterinair preparaat.
NL192030B (nl) Inrichting voor de elektrodialyse van vloeistoffen.
NL194956B (nl) Preparaat voor de afgifte van een heilzaam middel.
NL7904347A (nl) Roestwerend middel voor waterige systemen en roest- werende smeermiddelsamenstelling.
NL7714084A (nl) Van een deklaag voorziene constructies voor gebruik in zee.
NL7901673A (nl) Werkwijze en inrichting voor het bepalen van de posi- ties van reflectoren met behulp van waaiervormige bun- dels.
NL7700837A (nl) Beschermingsinrichting voor armen van een inzittende van een schietstoel.
NL181338B (nl) Controle-inrichting voor het onderzoeken van brieven.
NL188438C (nl) Inrichting voor het verwijderen van de bekleding van een in hoofdzaak staafvormig voorwerp.
NL193557B (nl) Inrichting voor het herschikken van divergerende bundels.
NL7810623A (nl) Inrichting voor het toevoeren van een toevoegmiddel in spoelwatersystemen of dergelijke.
NL7709779A (nl) Werkwijze voor het bereiden van een geexpandeerd perlietbevattend schuurreinigingsmiddel.
NL187084C (nl) Inrichting voor het overbrengen van een draaibeweging.
NL7704998A (nl) Werkwijze voor de bereiding en toepassing van een middel ter stimulering van de mimmunol- -ogische reactiviteit.
NL177973C (nl) Inrichting voor het in delen snijden van geslachte vogels.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20040301